Five adverts for Voy’s at-home testosterone blood tests have been banned after the Advertising Standards Authority found that they made misleading claims about symptoms associated with low testosterone in men.

The ruling covered three posters and two paid-for Facebook adverts from the online healthcare provider. The regulator objected to the way the promotions connected symptoms including irritability and fatigue with low testosterone, when such symptoms can have a range of possible causes.

Voy said it had taken the adverts down while the investigation was in progress and would not use them again. The company sells products including testosterone, menopause and weight-loss treatments.

What the watchdog found

The ASA said the adverts exaggerated the relationship between low testosterone and several common symptoms. Among the examples it identified were low sex drive, low energy, loss of motivation and changes in mood.

Some symptoms are more closely associated with testosterone deficiency than others, the regulator said. It found that less specific symptoms should not have been presented on their own as strong indicators of the condition.

One Facebook advert also claimed that low testosterone affected one in four men over 30. The ASA said the claim was misleading and that the evidence Voy supplied did not support it.

Dr Earim Chaudry, Voy’s chief medical officer, said patient decisions at the company were led by clinicians and that the campaigns had been developed to align with UK advertising standards. He said Voy continually reviewed its advertising to ensure it met updated guidance.

Health context and wider investigation

The NHS says testosterone levels in men fall with age, but that this is unlikely in itself to cause problems. It says a deficiency later in life can sometimes be responsible for symptoms including depression, loss of sex drive and erectile dysfunction, although such symptoms are often not linked to it.

Dr Richard Quinton, an expert in testosterone deficiency, said a healthy man could obtain a low testosterone result in several circumstances, including an afternoon blood test, a test after a meal, illness or staying up all night.

Some Voy test-kit adverts attracted criticism online after appearing on the London Underground earlier in the year. Critics described their wording as “ragebait”; Voy said at the time that it was trying to destigmatise conversations about men’s health.

The Voy decision followed two ASA rulings in August concerning misleading claims in adverts for testosterone testing services from BioID Health and Numan Digital Healthcare. The regulator said those cases formed part of a wider investigation into advertising aimed at men concerned about their health.

The ASA said it had identified a recurring pattern of advertisers playing on insecurities about libido, erectile problems, testosterone and ageing. It said adverts for low-testosterone tests and services were permitted, but their claims had to be accurate and supported by evidence.